Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammation Following Ocular Surgery”

68 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 68 results

Testing effectiveness (Phase 2)Study completedNCT02128113
What this trial is testing

RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD

Who this might be right for
Corneal Endothelial Cell LossOcular PainOcular Inflammation+1 more
Biogen 307
Post-approval studies (Phase 4)Study completedNCT04521140
What this trial is testing

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery

Who this might be right for
Corneal EdemaCorneal DefectCorneal Transplant+4 more
Nicole Fram M.D. 36
Not applicableStudy completedNCT00478764
What this trial is testing

Intraocular Steroid After Cataract Surgery Study

Who this might be right for
Cataract
Dean Health System 41
Large-scale testing (Phase 3)WithdrawnNCT01515826
What this trial is testing

VIGADEXA Gel Compared to VIGADEXA Solution Following Cataract Surgery

Who this might be right for
Cataracts
Alcon Research
Not applicableStudy completedNCT01694212
What this trial is testing

Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy

Who this might be right for
Macular EdemaCataractDiabetic Retinopathy
Eye Clinic Medic Zuljan Jukic 55
Large-scale testing (Phase 3)Ended earlyNCT01298752
What this trial is testing

Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery

Who this might be right for
InflammationPainCataract
Bausch & Lomb Incorporated 177
Large-scale testing (Phase 3)Study completedNCT02208297
What this trial is testing

Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Who this might be right for
InflammationPainCataract
Bausch & Lomb Incorporated 326
Large-scale testing (Phase 3)Study completedNCT04739709
What this trial is testing

Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery

Who this might be right for
Ocular Inflammation and Pain
Formosa Pharmaceuticals, Inc. 378
Testing effectiveness (Phase 2)UnknownNCT00353964
What this trial is testing

Safety and Efficacy Study of rEV131 in the Treatment of Ocular Inflammation After Cataract Surgery

Who this might be right for
Ocular Inflammation
Evolutec Group
Large-scale testing (Phase 3)Study completedNCT00699153
What this trial is testing

Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery

Who this might be right for
Ocular Inflammation
Bausch & Lomb Incorporated 400
Post-approval studies (Phase 4)Study completedNCT02137161
What this trial is testing

Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery

Who this might be right for
CataractPseudoexfoliation Syndrome
Azienda USL Reggio Emilia - IRCCS 62
Large-scale testing (Phase 3)Study completedNCT01230125
What this trial is testing

Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery

Who this might be right for
Cataract
Bausch & Lomb Incorporated 311
Large-scale testing (Phase 3)Study completedNCT01124045
What this trial is testing

Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery

Who this might be right for
CataractsInflammation
Alcon Research 80
Large-scale testing (Phase 3)Study completedNCT05147233
What this trial is testing

Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Who this might be right for
Inflammation Eye PainPostoperative Cataract
Oculis 241
Large-scale testing (Phase 3)Study completedNCT04539548
What this trial is testing

A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract

Who this might be right for
Cataract
Ocular Therapeutix, Inc. 65
Post-approval studies (Phase 4)Study completedNCT04631315
What this trial is testing

Difluprednate vs. a Prednisolone Acetate - Phenylephrine on Post-operative Inflammation Following Cataract Surgery.

Who this might be right for
Cataract
Laboratorios Poen 255
Large-scale testing (Phase 3)Study completedNCT02034019
What this trial is testing

Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery

Who this might be right for
Post Ocular Surgical Inflammation and Pain
Ocular Therapeutix, Inc. 247
Testing effectiveness (Phase 2)Study completedNCT06164743
What this trial is testing

Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery

Who this might be right for
Inflammation
VivaVision Biotech, Inc 91
Early research (Phase 1)Ended earlyNCT01605942
What this trial is testing

A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery

Who this might be right for
Cataract
Allergan 8
Large-scale testing (Phase 3)Study completedNCT04810962
What this trial is testing

Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study

Who this might be right for
Ocular Inflammation and Pain After Cataract Surgery
Formosa Pharmaceuticals, Inc. 370
Next Page